The Initiative & Finance Group has acquired the share capital of CSD Engineers Group. This new partnership will enable CSD to achieve its growth ambitions as a leading engineering company in Switzerland and abroad. With
Niederer Kraft Frey has advised Bearmind as Swiss counsel on its seed financing round led by HH Equity Partners II. The EPFL spinoff has secured CHF 1.3 million in the seed round that also included participation
Fundamenta Group Holding has acquired 100% of the shares of Belvédère Asset Management. In return, the previous shareholders of Belvédère Asset Management will acquire a stake in Fundamenta Group. Following the closing
Niederer Kraft Frey advised Clariant in connection with its new CHF 450 million sustainability-linked syndicated revolving credit facility agreement with Skandinaviska Enskilda Banken, Citibank, BNP Paribas, Commerzbank, Credit Suisse, Deutsche Bank and UBS acting as bookrunners
The Swiss startup AICA has closed a CHF 1.2 million financing round to give robots a sense of touch and enable autonomous learning. Niederer Kraft Frey advised AICA as Swiss counsel on its seed financing round
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 mio (approx. USD 112 mio). The round was co-led by the European healthcare focused
Santhera Pharmaceuticals Holding announced a private placement of shares and an amendment of its existing financing with funds managed by Highbridge Capital Management to provide up to CHF 22.2 million in aggregate, subject to certain milestones
Tamara Teves joins Advoro (Advokatur am Rosenberg) from MME Legal, where she is now a partner. Tamara Teves is a specialist in financial markets law and has particular expertise and extensive experience in the legal
BianchiSchwald is currently sponsoring the HSG Moot Court Team, consisting of Filippo Börner and Manuel J. Constam and supported by Tanja Wohlgemuth and Fabio von May, in view of its participation in the Vis
The German life science and medtech private equity firm SHS Capital has made a EUR 10 million investment in Simulands, a Swiss manufacturer of simulation devices for medical training of cardiovascular interventions. The investment aims to
